SOCIAL RESPONSIBILITY AS THE MISSING ELEMENT IN PHARMACEUTICAL PUBLIC RELATIONS: A DIPLOMATIC PROPOSAL FOR MANDATED DISCLOSURE OF NATURAL PROCREATIVE HYGIENE AND APPROPRIATE-AGE INFORMATION

Pharmaceutical public relations is among the most capital-intensive communication enterprises onearth, capable of placing a single message before much of humanity within days. This essay advances aconstructive observation: the element missing from that machinery is not science, and it is not sincerity— it is completed social responsibility. The industry already operates under mandated disclosure ofadverse information (package inserts, contraindication warnings, tobacco-style labeling precedents),proving that commercial channels can carry truths adverse to commercial interest when the publicinterest requires it. We propose extending this settled principle one step further: as a condition ofmarketing fertility-related and maternal-health products, the industry's communication infrastructurewould carry, verbatim and without editorial framing, brief standardized information on (1) non-patented, non-product fertility-awareness methods collectively termed Natural Procreative Hygiene(NPH), documented in the scholarly record for centuries, and (2) established information onappropriate childbearing ages currently absent from medical standards. The proposal is framedthroughout as an opportunity: the industry possesses the only distribution capital capable of reachingthe world's population at scale, and disclosure completed is trust earned. A further possibility isaddressed: that the industry, or its adjacent technology sector, might assert that it invented thesemethods, or holds patents upon them, and therefore owns the category. The essay shows why such aclaim, if made, strengthens rather than defeats the proposal — and why the underlying knowledge,being prior art of the oldest kind, belongs to no patent office. We argue that this "attention invoice" —the obligation of a channel that profits from public attention to pay for it in public information — is thenatural completion of the industry's own stated ESG commitments, not a constraint upon them.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-15
DOI
https://doi.org/10.5281/zenodo.24236164
Primary Topic
Pharmaceutical industry and healthcare
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

SOCIAL RESPONSIBILITY AS THE MISSING ELEMENT IN PHARMACEUTICAL PUBLIC RELATIONS: A DIPLOMATIC PROPOSAL FOR MANDATED DISCLOSURE OF NATURAL PROCREATIVE HYGIENE AND APPROPRIATE-AGE INFORMATION

Kasey George
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical industry and healthcare
preprint

SOCIAL RESPONSIBILITY AS THE MISSING ELEMENT IN PHARMACEUTICAL PUBLIC RELATIONS: A DIPLOMATIC PROPOSAL FOR MANDATED DISCLOSURE OF NATURAL PROCREATIVE HYGIENE AND APPROPRIATE-AGE INFORMATION

Kasey George
preprint en

Abstract

Pharmaceutical public relations is among the most capital-intensive communication enterprises onearth, capable of placing a single message before much of humanity within days. This essay advances aconstructive observation: the element missing from that machinery is not science, and it is not sincerity— it is completed social responsibility. The industry already operates under mandated disclosure ofadverse information (package inserts, contraindication warnings, tobacco-style labeling precedents),proving that commercial channels can carry truths adverse to commercial interest when the publicinterest requires it. We propose extending this settled principle one step further: as a condition ofmarketing fertility-related and maternal-health products, the industry's communication infrastructurewould carry, verbatim and without editorial framing, brief standardized information on (1) non-patented, non-product fertility-awareness methods collectively termed Natural Procreative Hygiene(NPH), documented in the scholarly record for centuries, and (2) established information onappropriate childbearing ages currently absent from medical standards. The proposal is framedthroughout as an opportunity: the industry possesses the only distribution capital capable of reachingthe world's population at scale, and disclosure completed is trust earned. A further possibility isaddressed: that the industry, or its adjacent technology sector, might assert that it invented thesemethods, or holds patents upon them, and therefore owns the category. The essay shows why such aclaim, if made, strengthens rather than defeats the proposal — and why the underlying knowledge,being prior art of the oldest kind, belongs to no patent office. We argue that this "attention invoice" —the obligation of a channel that profits from public attention to pay for it in public information — is thenatural completion of the industry's own stated ESG commitments, not a constraint upon them.

Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical industry and healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon